Seyama Shoji, Wajima Takeaki, Yanagisawa Yuki, Nakaminami Hidemasa, Ushio Masanobu, Fujii Takeshi, Noguchi Norihisa
From the *Department of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences; †Department of Pediatrics, and ‡Department of Infectious Diseases, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan.
Pediatr Infect Dis J. 2017 Mar;36(3):263-266. doi: 10.1097/INF.0000000000001415.
β-Lactamase-nonproducing ampicillin-resistant Haemophilus influenzae are prevalent in Japan. Resistance has increased as a consequence of the expanded use of antimicrobial agents, raising concerns about the rise of multidrug (macrolide and fluoroquinolone)-resistant H. influenzae.
In this study, we investigated susceptibility to fluoroquinolones in H. influenzae clinical isolates from 2013 to 2014 and identified the amino acid substitutions in quinolone resistance-determining regions of gyrA and parC.
All isolates (n = 145) were susceptible to fluoroquinolones; however, some showed reduced susceptibility. The minimum inhibitory concentration of levofloxacin for these strains was 0.063-0.5 µg/mL, and the strains harbored the amino acid substitution S84L in GyrA. Such strains have seen a significant increase. Importantly, all mutants from 2014 were isolated from pediatric patients. In addition, we developed a simple polymerase chain reaction-based screening method for detecting isolates with reduced fluoroquinolone susceptibility.
The mutation in GyrA is important as a first step in the development of fluoroquinolone resistance. Hence, detection of reduced susceptible strains may influence the choice of antimicrobial treatment.
在日本,不产β-内酰胺酶的耐氨苄西林流感嗜血杆菌很常见。由于抗菌药物使用的增加,耐药性有所上升,这引发了对多重耐药(大环内酯类和氟喹诺酮类)流感嗜血杆菌增加的担忧。
在本研究中,我们调查了2013年至2014年流感嗜血杆菌临床分离株对氟喹诺酮类的敏感性,并确定了gyrA和parC喹诺酮耐药决定区的氨基酸替换。
所有分离株(n = 145)对氟喹诺酮类敏感;然而,一些分离株显示敏感性降低。这些菌株对左氧氟沙星的最低抑菌浓度为0.063 - 0.5 μg/mL,并且菌株在GyrA中存在氨基酸替换S84L。此类菌株显著增加。重要的是,2014年的所有突变株均从儿科患者中分离得到。此外,我们开发了一种基于聚合酶链反应的简单筛选方法,用于检测氟喹诺酮敏感性降低的分离株。
GyrA中的突变作为氟喹诺酮耐药性发展的第一步很重要。因此,检测敏感性降低的菌株可能会影响抗菌治疗的选择。